Sistemic to Work with TiGenix On FP7 European Project Aiming at Developing an Innovative Rheumatoid Arthritis Cell Therapy Treatment Product
09-Feb-2012 -
Sistemic announced that its proprietary technology (SistemQC™) has been chosen to form a key part of the research and production process for a landmark multinational collaborative project led by TiGenix, Belgium and including partners from Spain, France, the Netherlands as well as the UK and ...
rheumatoid arthritis
stem cell therapie